Ignite Creation Date:
2024-05-06 @ 7:57 AM
Last Modification Date:
2024-10-26 @ 11:54 AM
Study NCT ID:
NCT02638909
Status:
TERMINATED
Last Update Posted:
2018-04-02
First Post:
2015-12-15
Brief Title:
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
Sponsor:
Criterium Inc
Organization:
Criterium Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Esophageal Adenocarcinoma |
| Colorectal Adenocarcinoma |
| Cholangiocarcinoma |
| Pancreatic Adenocarcinoma |
| Hepatocellular Adenocarcinoma |
| Gastric Adenocarcinoma |
Keywords:
| Name | View |
|---|---|
| Gastrointestinal malignancies | View |